HERON THERAPEUTICS, INC. /DE/ Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit
HERON THERAPEUTICS, INC. /DE/ (HRTX) reported Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit of $38.46 per share for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-27.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit · last filed 2018-02-27
- HERON THERAPEUTICS, INC. /DE/ share-based payment arrangement, option, exercise price range, upper range limit for fiscal 2017 was $38.46, a 62.44% decline from fiscal 2016.
- HERON THERAPEUTICS, INC. /DE/ share-based payment arrangement, option, exercise price range, upper range limit for fiscal 2016 was $102.40.
| Period end | Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit 12 month |
|---|---|
| 2017-12-31 | $38.46 10-K · filed 2018-02-27 |
| 2016-12-31 | $102.40 10-K · filed 2017-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |